Free Trial

Best Stocks Under $5 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $5.00 (5 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

atai Life Sciences stock logo

1. atai Life Sciences NASDAQ:ATAI

$2.62 -0.11 (-4.03%)
Closing price 04:00 PM Eastern
Extended Trading
$2.62 0.00 (-0.04%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Atai Life Sciences N.V., a clinical-stage biopharmaceutical company, develops and invests in various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. More about atai Life Sciences

Market Capitalization
$546.92 million
P/E Ratio
-2.88
Consensus Rating
Strong Buy
Consensus Price Target
$9.00 (+243.5% Upside)
Volume
2.87 million shares
Average Volume
2.09 million shares
Telecom Italia stock logo

2. Telecom Italia OTCMKTS:TIIAY

$4.69 -0.04 (-0.89%)
As of 03:20 PM Eastern

Telecom Italia S.p.A., together with its subsidiaries, engages in the provision of fixed and mobile telecommunications services in Italy and internationally. More about Telecom Italia

Consensus Rating
Buy
Volume
1,286 shares
Average Volume
13,560 shares
Today's Range
$4.68
$4.69
50-Day Range
$3.95
$4.90
52-Week Range
$2.19
$4.90
TuHURA Biosciences stock logo

3. TuHURA Biosciences NASDAQ:HURA

$2.30 -0.22 (-8.73%)
Closing price 04:00 PM Eastern
Extended Trading
$2.42 +0.13 (+5.43%)
As of 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TuHURA Biosciences, Inc (NASDAQ: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. More about TuHURA Biosciences

Market Capitalization
$110.07 million
Consensus Rating
Buy
Consensus Price Target
$12.67 (+450.7% Upside)
Volume
215,840 shares
Average Volume
262,863 shares
Today's Range
$2.28
$2.55
zSpace stock logo

4. zSpace NASDAQ:ZSPC

$2.77 -0.09 (-3.15%)
As of 04:00 PM Eastern

zSpace Technologies, Inc is a provider of commercial augmented reality and virtual reality technology principally in the education market. More about zSpace

Market Capitalization
$65.44 million
Consensus Rating
Buy
Consensus Price Target
$15.00 (+441.5% Upside)
Volume
52,455 shares
Average Volume
52,788 shares
Today's Range
$2.70
$2.87
OS Therapies stock logo

5. OS Therapies NYSE:OSTX

$1.70 +0.03 (+1.80%)
Closing price 04:00 PM Eastern
Extended Trading
$1.69 -0.01 (-0.59%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. More about OS Therapies

Market Capitalization
$47.77 million
P/E Ratio
-1.98
Consensus Rating
Buy
Consensus Price Target
$18.00 (+958.8% Upside)
Volume
344,129 shares
Average Volume
490,705 shares
Western Copper & Gold stock logo

6. Western Copper & Gold NYSE:WRN

$1.33 +0.01 (+0.76%)
As of 04:00 PM Eastern

Western Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & Gold

Market Capitalization
$266.31 million
P/E Ratio
-66.50
Consensus Rating
Buy
Consensus Price Target
$4.00 (+200.8% Upside)
Volume
440,961 shares
Average Volume
376,385 shares
OnKure Therapeutics stock logo

7. OnKure Therapeutics NASDAQ:OKUR

$2.50 -0.05 (-1.96%)
Closing price 04:00 PM Eastern
Extended Trading
$2.58 +0.09 (+3.40%)
As of 06:29 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OnKure Therapeutics, Inc engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. More about OnKure Therapeutics

Market Capitalization
$34.45 million
P/E Ratio
-0.48
Consensus Rating
Buy
Consensus Price Target
$32.33 (+1,193.3% Upside)
Volume
90,638 shares
Average Volume
107,083 shares
GeoVax Labs stock logo

8. GeoVax Labs NASDAQ:GOVX

$0.68 +0.01 (+1.32%)
As of 04:00 PM Eastern

GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. More about GeoVax Labs

Market Capitalization
$10.62 million
P/E Ratio
-0.19
Consensus Rating
Buy
Consensus Price Target
$11.10 (+1,542.7% Upside)
Volume
1.97 million shares
Average Volume
3.17 million shares
MannKind stock logo

9. MannKind NASDAQ:MNKD

$3.77 -0.03 (-0.79%)
Closing price 04:00 PM Eastern
Extended Trading
$3.78 +0.01 (+0.16%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. More about MannKind

Market Capitalization
$1.15 billion
P/E Ratio
37.70
Consensus Rating
Buy
Consensus Price Target
$10.33 (+174.1% Upside)
Volume
1.82 million shares
Average Volume
2.44 million shares
Quince Therapeutics stock logo

10. Quince Therapeutics NASDAQ:QNCX

$1.82 +0.04 (+2.25%)
Closing price 04:00 PM Eastern
Extended Trading
$1.88 +0.06 (+3.30%)
As of 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince Therapeutics

Market Capitalization
$80.93 million
P/E Ratio
-1.31
Consensus Rating
Buy
Consensus Price Target
$8.00 (+339.6% Upside)
Volume
492,644 shares
Average Volume
312,838 shares
Denison Mine stock logo

11. Denison Mine NYSEAMERICAN:DNN

$1.78 +0.05 (+2.89%)
Closing price 04:10 PM Eastern
Extended Trading
$1.78 -0.01 (-0.28%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison Mine

Market Capitalization
$1.55 billion
P/E Ratio
-22.25
Consensus Rating
Buy
Consensus Price Target
$3.00 (+68.5% Upside)
Volume
60.52 million shares
Average Volume
51.38 million shares
Reviva Pharmaceuticals stock logo

12. Reviva Pharmaceuticals NASDAQ:RVPH

$0.39 0.00 (-0.20%)
Closing price 04:00 PM Eastern
Extended Trading
$0.40 +0.01 (+1.74%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva Pharmaceuticals

Market Capitalization
$18.82 million
P/E Ratio
-0.50
Consensus Rating
Buy
Consensus Price Target
$9.00 (+2,200.6% Upside)
Volume
2.74 million shares
Average Volume
1.41 million shares
Hochschild Mining stock logo

13. Hochschild Mining OTCMKTS:HCHDF

$3.83 +0.22 (+6.09%)
As of 02:23 PM Eastern

Hochschild Mining plc, a precious metals company, engages in the exploration, mining, processing, and sale of gold and silver in the Americas. More about Hochschild Mining

Market Capitalization
$1.86 billion
Consensus Rating
Buy
Volume
1,055 shares
Average Volume
18,355 shares
Today's Range
$3.80
$3.92
50-Day Range
$3.20
$4.21
Immunic stock logo

14. Immunic NASDAQ:IMUX

$0.83 -0.01 (-0.92%)
Closing price 04:00 PM Eastern
Extended Trading
$0.84 +0.01 (+1.31%)
As of 07:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about Immunic

Market Capitalization
$80.28 million
P/E Ratio
-0.67
Consensus Rating
Buy
Consensus Price Target
$11.60 (+1,297.4% Upside)
Volume
439,488 shares
Average Volume
981,412 shares
Full House Resorts stock logo

15. Full House Resorts NASDAQ:FLL

$4.52 +0.02 (+0.44%)
Closing price 04:00 PM Eastern
Extended Trading
$4.59 +0.07 (+1.57%)
As of 06:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Full House Resorts, Inc owns, leases, operates, develops, manages, and invests in casinos, and related hospitality and entertainment facilities in the United States. More about Full House Resorts

Market Capitalization
$161.89 million
P/E Ratio
-4.07
Consensus Rating
Buy
Consensus Price Target
$5.67 (+25.4% Upside)
Volume
134,708 shares
Average Volume
175,827 shares
Rezolve AI stock logo

16. Rezolve AI NASDAQ:RZLV

$2.54 -0.08 (-3.05%)
Closing price 04:00 PM Eastern
Extended Trading
$2.56 +0.02 (+0.63%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Rezolve AI Plc operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. More about Rezolve AI

Market Capitalization
$545.64 million
Consensus Rating
Buy
Consensus Price Target
$6.00 (+136.2% Upside)
Volume
5.87 million shares
Average Volume
5.65 million shares
Today's Range
$2.44
$2.65
TriSalus Life Sciences stock logo

17. TriSalus Life Sciences NASDAQ:TLSI

$4.89 -0.11 (-2.20%)
Closing price 04:00 PM Eastern
Extended Trading
$4.88 0.00 (-0.10%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TriSalus Life Sciences, Inc, a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. More about TriSalus Life Sciences

Market Capitalization
$189.20 million
P/E Ratio
-4.37
Consensus Rating
Buy
Consensus Price Target
$10.75 (+119.8% Upside)
Volume
27,428 shares
Average Volume
52,062 shares
Alumis stock logo

18. Alumis NASDAQ:ALMS

$3.52 -0.04 (-1.12%)
Closing price 04:00 PM Eastern
Extended Trading
$3.54 +0.02 (+0.43%)
As of 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Our mission is to significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. More about Alumis

Market Capitalization
$193.68 million
Consensus Rating
Buy
Consensus Price Target
$22.86 (+549.4% Upside)
Volume
489,132 shares
Average Volume
435,202 shares
Today's Range
$3.50
$3.65
Electrovaya stock logo

19. Electrovaya NASDAQ:ELVA

$3.83 +0.04 (+1.06%)
Closing price 03:58 PM Eastern
Extended Trading
$3.82 0.00 (-0.13%)
As of 05:01 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Electrovaya Inc engages in the design, development, manufacture, and sale of lithium-ion batteries, battery management systems, and battery-related products for energy storage, clean electric transportation, and other specialized applications in North America. More about Electrovaya

Market Capitalization
$152.01 million
Consensus Rating
Buy
Consensus Price Target
$6.10 (+59.3% Upside)
Volume
171,139 shares
Average Volume
62,879 shares
Today's Range
$3.67
$3.89
ImmunityBio stock logo

20. ImmunityBio NASDAQ:IBRX

$2.81 -0.06 (-2.09%)
Closing price 04:00 PM Eastern
Extended Trading
$2.82 +0.02 (+0.53%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ImmunityBio, Inc, a clinical-stage biotechnology company, engages in developing therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. More about ImmunityBio

Market Capitalization
$2.53 billion
P/E Ratio
-4.84
Consensus Rating
Buy
Consensus Price Target
$12.25 (+335.9% Upside)
Volume
6.02 million shares
Average Volume
6.27 million shares
Ovid Therapeutics stock logo

21. Ovid Therapeutics NASDAQ:OVID

$0.40 -0.01 (-3.34%)
Closing price 04:00 PM Eastern
Extended Trading
$0.41 +0.01 (+1.98%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Ovid Therapeutics Inc, a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. More about Ovid Therapeutics

Market Capitalization
$29.80 million
P/E Ratio
-1.16
Consensus Rating
Buy
Consensus Price Target
$3.13 (+671.6% Upside)
Volume
584,241 shares
Average Volume
448,063 shares
Stardust Power stock logo

22. Stardust Power NASDAQ:SDST

$0.25 +0.02 (+9.14%)
Closing price 04:00 PM Eastern
Extended Trading
$0.49 +0.24 (+95.63%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.

Market Capitalization
$13.89 million
P/E Ratio
-0.34
Consensus Rating
Buy
Consensus Price Target
$5.11 (+1,928.8% Upside)
Volume
9.34 million shares
Average Volume
899,827 shares
United States Antimony stock logo

23. United States Antimony NYSE:UAMY

$2.72 +0.06 (+2.26%)
Closing price 04:00 PM Eastern
Extended Trading
$2.72 0.00 (0.00%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

United States Antimony Corporation produces and sells antimony, silver, gold, precious metals, and zeolite products in the United States, and Canada. More about United States Antimony

Market Capitalization
$323.96 million
P/E Ratio
-68.00
Consensus Rating
Buy
Consensus Price Target
$3.38 (+24.1% Upside)
Volume
4.01 million shares
Average Volume
2.80 million shares
Mereo BioPharma Group stock logo

24. Mereo BioPharma Group NASDAQ:MREO

$1.61 -0.08 (-4.73%)
Closing price 04:00 PM Eastern
Extended Trading
$1.60 -0.01 (-0.31%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. More about Mereo BioPharma Group

Market Capitalization
$268.71 million
P/E Ratio
-23.00
Consensus Rating
Buy
Consensus Price Target
$7.20 (+347.2% Upside)
Volume
9.42 million shares
Average Volume
1.30 million shares
Lucid Diagnostics stock logo

25. Lucid Diagnostics NASDAQ:LUCD

$1.14 -0.04 (-3.39%)
Closing price 04:00 PM Eastern
Extended Trading
$1.14 +0.00 (+0.35%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lucid Diagnostics Inc operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. More about Lucid Diagnostics

Market Capitalization
$127.66 million
P/E Ratio
-0.85
Consensus Rating
Buy
Consensus Price Target
$3.55 (+211.4% Upside)
Volume
1.55 million shares
Average Volume
687,998 shares